Inactive Instrument
InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 161M 490M 142M 132M 121M 227M 15.53B 230M 1.56B 610M 7.61B 604M 591M 26.34B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 297M 906M 261M 243M 223M 419M 28.69B 426M 2.89B 1.13B 14.06B 1.12B 1.09B 48.67B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 29/02/2020 |
Itai Kabiljo
LAW | General Counsel | - | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 02/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 13/12/2014 |
| Chairman | 55 | 12/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 51.28M | |
| -1.03% | +0.52% | +37.86% | +221.67% | 223M | |
| +2.15% | -1.04% | +6.74% | +111.11% | 130M | |
| +3.12% | +7.32% | -37.14% | -26.26% | 128M | |
| -0.25% | -11.09% | -9.72% | -11.17% | 80.1M | |
| -6.02% | -7.14% | -2.50% | -40.91% | 84.23M | |
| Average | -0.30% | -1.91% | -0.95% | +50.89% | 129.09M | |
| Weighted average by Cap. | -0.09% | -0.79% | +5.54% | +87.06% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 728M 210M 195M 179M 337M 23.06B 342M 2.32B 906M 11.3B 897M 877M 39.12B | 270M 824M 238M 221M 203M 381M 26.09B 387M 2.62B 1.02B 12.79B 1.01B 992M 44.26B |
| Net income | -67.8M -207M -59.65M -55.44M -50.9M -95.54M -6.55B -97.14M -658M -257M -3.21B -254M -249M -11.1B | -35.71M -109M -31.42M -29.2M -26.81M -50.32M -3.45B -51.17M -347M -135M -1.69B -134M -131M -5.85B |
| Net Debt | 133M 405M 117M 109M 99.67M 187M 12.82B 190M 1.29B 503M 6.28B 498M 488M 21.74B | 136M 416M 120M 111M 102M 192M 13.16B 195M 1.32B 517M 6.45B 512M 501M 22.33B |
Employees
-
